+91-98 455 710 46 | info@nckpharma.com

orphan drug designation

Allena’s oxalate decarboxylase to treat paediatric hyperoxaluria gets US FDA orphan drug status

Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercialising innovative, non-systemic, oral protein therapeutics to treat metabolic and orphan...
Read More

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests